Research ArticleArticle
Classification and Diagnostic Investigation in Inflammatory Myopathies: A Study of 99 Patients
Olof Danielsson, Björn Lindvall, Istvan Gati and Jan Ernerudh
The Journal of Rheumatology May 2013, jrheum.120804; DOI: https://doi.org/10.3899/jrheum.120804
Olof Danielsson
From the Department of Clinical and Experimental Medicine, Division of Neurology and Division of Clinical Immunology, Faculty of Health Sciences, Linköping University, Linköping; Department of Neurology and Department of Clinical Immunology and Transfusion Medicine, County Council of Östergötland, Linköping; and the Department of Neurology, University Hospital Örebro, Örebro, Sweden. Supported by the University Hospital Linköping and the County Council of Östergötland. O. Danielsson, MD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; B. Lindvall, MD, PhD, Department of Neurology, University Hospital Örebro; I. Gati, MD, PhD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; J. Ernerudh, MD, Professor, Department of Clinical Immunology and Transfusion Medicine and Department of Clinical and Experimental Medicine, Division of Clinical Immunology, Faculty of Health Sciences, Linköping University. Address correspondence to Dr. O. Danielsson, Department of Neurology, University Hospital, SE-58185 Linköping, Sweden. E-mail: olof.danielsson@lio.se Accepted for publication February 14, 2013.
Björn Lindvall
From the Department of Clinical and Experimental Medicine, Division of Neurology and Division of Clinical Immunology, Faculty of Health Sciences, Linköping University, Linköping; Department of Neurology and Department of Clinical Immunology and Transfusion Medicine, County Council of Östergötland, Linköping; and the Department of Neurology, University Hospital Örebro, Örebro, Sweden. Supported by the University Hospital Linköping and the County Council of Östergötland. O. Danielsson, MD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; B. Lindvall, MD, PhD, Department of Neurology, University Hospital Örebro; I. Gati, MD, PhD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; J. Ernerudh, MD, Professor, Department of Clinical Immunology and Transfusion Medicine and Department of Clinical and Experimental Medicine, Division of Clinical Immunology, Faculty of Health Sciences, Linköping University. Address correspondence to Dr. O. Danielsson, Department of Neurology, University Hospital, SE-58185 Linköping, Sweden. E-mail: olof.danielsson@lio.se Accepted for publication February 14, 2013.
Istvan Gati
From the Department of Clinical and Experimental Medicine, Division of Neurology and Division of Clinical Immunology, Faculty of Health Sciences, Linköping University, Linköping; Department of Neurology and Department of Clinical Immunology and Transfusion Medicine, County Council of Östergötland, Linköping; and the Department of Neurology, University Hospital Örebro, Örebro, Sweden. Supported by the University Hospital Linköping and the County Council of Östergötland. O. Danielsson, MD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; B. Lindvall, MD, PhD, Department of Neurology, University Hospital Örebro; I. Gati, MD, PhD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; J. Ernerudh, MD, Professor, Department of Clinical Immunology and Transfusion Medicine and Department of Clinical and Experimental Medicine, Division of Clinical Immunology, Faculty of Health Sciences, Linköping University. Address correspondence to Dr. O. Danielsson, Department of Neurology, University Hospital, SE-58185 Linköping, Sweden. E-mail: olof.danielsson@lio.se Accepted for publication February 14, 2013.
Jan Ernerudh
From the Department of Clinical and Experimental Medicine, Division of Neurology and Division of Clinical Immunology, Faculty of Health Sciences, Linköping University, Linköping; Department of Neurology and Department of Clinical Immunology and Transfusion Medicine, County Council of Östergötland, Linköping; and the Department of Neurology, University Hospital Örebro, Örebro, Sweden. Supported by the University Hospital Linköping and the County Council of Östergötland. O. Danielsson, MD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; B. Lindvall, MD, PhD, Department of Neurology, University Hospital Örebro; I. Gati, MD, PhD, Department of Neurology and Department of Clinical and Experimental Medicine, Division of Neurology, Faculty of Health Sciences, Linköping University; J. Ernerudh, MD, Professor, Department of Clinical Immunology and Transfusion Medicine and Department of Clinical and Experimental Medicine, Division of Clinical Immunology, Faculty of Health Sciences, Linköping University. Address correspondence to Dr. O. Danielsson, Department of Neurology, University Hospital, SE-58185 Linköping, Sweden. E-mail: olof.danielsson@lio.se Accepted for publication February 14, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Classification and Diagnostic Investigation in Inflammatory Myopathies: A Study of 99 Patients
Olof Danielsson, Björn Lindvall, Istvan Gati, Jan Ernerudh
The Journal of Rheumatology May 2013, jrheum.120804; DOI: 10.3899/jrheum.120804